Cardiogenic Shock
American College of Cardiology
APRIL 7, 2024
The goal of the DanGer Shock trial was to compare the safety and efficacy of Impella CP on top of standard care compared with standard care alone among patients with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock.
Let's personalize your content